Keyword: Food and Drug Administration (FDA)
News
05.01.2016
- Swedish drugmaker AstraZeneca has gained approval from the US Food and Drug Administration (FDA) to market Zurampic, a treatment for gout, the debilitating form of inflammatory...
News
09.12.2015
- US President Barack Obama has signed into law a Congressional bill extending exclusivity periods for new drugs and biologics containing a controlled substance. The extension will...
News
02.12.2015
- US biopharmaceutical company Baxalta has received European marketing approval for its hemophilia treatment Obizur. The drug is said to be the first recombinant porcine sequence...
News
02.12.2015
- Express Scripts Holding, the biggest pharmacy benefits manager in the US, said it plans to list Imprimis Pharmaceuticals’ cheaper alternative to the toxoplasmosis treatment...
News
23.11.2015
- Singapore-based biotechnology firm Aslan Pharmaceuticals, which specializes in immunotherapy and targeted agents for cancer forms prevalent in Asia, has agreed to cooperate with...
News
19.11.2015
- A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...
News
11.11.2015
- The US Food and Drug Administration (FDA) has approved Gilead Sciences’ Genvoya to treat HIV-1 infection. Genvoya combines four treatments – elvitegravir, cobicistat, emtricitabine...
News
08.11.2015
- Anglo-Swedish drugs firm AstraZeneca has unveiled plans to buy US biopharmaceutical company ZS Pharma, in a move that boosts its portfolio for treating cardiovascular and metabolic...